Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Cellular Biomedicine Group, Inc. (CBMG)

Income Statement Business | Product

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15Dec-31-14Dec-31-13Dec-31-12
   10-K10-K10-K10-K10-K10-K10-K10-K/A
Total revenues  0.30.20.30.62.50.60.29.4
            Revenue growth  51.5%-33.4%-46.4%-74.9%343.9%175.4%-97.8%3192.2%
Cost of goods sold  0.10.10.20.91.90.20.30.0
Gross profit  0.30.10.2-0.20.60.3-0.19.4
            Gross margin  81.6%39.5%51.8%-37.0%24.9%57.1%-44.6%100.0%
Selling, general and administrative   [+]13.613.513.112.113.88.29.21.5
Research and development  37.724.214.611.57.63.12.0 
Other operating expenses   2.9 4.60.11.4  
EBITDA   [+]-45.4-35.5-24.6-25.8-18.8-11.3-10.5 
            EBITDA margin  -13342.5%-15800.2%-7300.9%-4105.6%-748.5%-1993.7%-5130.1%84.1%
Depreciation and amortization  5.65.03.02.62.11.20.8 
EBIT   [+]-51.0-40.5-27.6-28.4-20.8-12.4-11.47.9
            EBIT margin  -15001.2%-18050.4%-8187.4%-4525.2%-832.2%-2204.6%-5540.7%84.1%
Interest income, net   [+]0.80.40.10.10.00.00.00.0
Other income (expense), net   [+]0.71.22.00.10.60.10.01.4
Pre-tax income  -50.0-38.9-25.5-28.2-20.2-12.4-11.49.3
Income taxes  0.00.00.00.0-0.70.02.40.1
            Tax rate      3.6%0.0% 0.9%
Earnings from continuing ops  -50.0-38.9-25.5-28.2-19.4-12.4-11.49.2
Earnings from discontinued ops       -3.1-2.4 
Net income  -50.0-38.9-25.5-28.2-19.4-15.5-13.89.2
            Net margin  -14704.7%-17355.2%-7568.0%-4492.3%-776.2%-2741.9%-6733.1%98.2%
   
Basic EPS   [+]($2.63)($2.20)($1.78)($2.09)($1.70)($1.43)($1.96)$5.91
Diluted EPS   [+]($2.63)($2.20)($1.78)($2.09)($1.70)($1.43)($1.96)$5.91
   
Shares outstanding (basic)   [+]19.017.714.313.511.58.65.81.6
Shares outstanding (diluted)   [+]19.017.714.313.511.58.65.81.6
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy